Literature DB >> 25063186

Hypothalamic and Limbic System Changes in Huntington's Disease.

Asa Petersén1, Sanaz Gabery2.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene. Today, the clinical diagnosis of the disease requires unequivocal signs of typical motor disturbances, which is thought to be due to pathology in the striatum of the basal ganglia. Increasing numbers of studies have emphasized that also non-motor symptoms and signs are common and occur early in HD. These include psychiatric disturbances and cognitive impairment as well as sleep disturbances with disrupted circadian rhythm, autonomic dysfunction and metabolic changes. Several of the non-motor features may be results of dysfunction of the hypothalamus and the limbic system, which are interconnected structures central in the regulation of emotion, sleep and metabolism. In fact, recent studies using postmortem tissue, magnetic resonance imaging and positron emission tomography have shown that hypothalamic and limbic system changes occur early in clinical HD. This review summarizes the current state of knowledge in this area based on clinical studies as well as experiments in animal models of the disease and establishes that hypothalamic and limbic system changes are part of the HD pathology.

Entities:  

Keywords:  Huntingtin; amygdala; huntington; hypothalamus; orexin; oxytocin

Mesh:

Year:  2012        PMID: 25063186     DOI: 10.3233/JHD-2012-120006

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  19 in total

1.  Oxytocin Prevents the Development of 3-NP-Induced Anxiety and Depression in Male and Female Rats: Possible Interaction of OXTR and mGluR2.

Authors:  Fariba Khodagholi; Ali Maleki; Fereshteh Motamedi; Maryam Alsadat Mousavi; Shahrbanoo Rafiei; Mehdi Moslemi
Journal:  Cell Mol Neurobiol       Date:  2020-11-17       Impact factor: 5.046

2.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

3.  Autonomic dysregulation as an early pathologic feature of Huntington Disease.

Authors:  Jordan L Schultz; Lyndsay A Harshman; John A Kamholz; Peg C Nopoulos
Journal:  Auton Neurosci       Date:  2021-02-05       Impact factor: 3.145

4.  The sleep and circadian problems of Huntington's disease: when, why and their importance.

Authors:  Z Voysey; S V Fazal; A S Lazar; R A Barker
Journal:  J Neurol       Date:  2020-12-23       Impact factor: 4.849

5.  Effects of a One Year Intensive Multidisciplinary Rehabilitation Program for Patients with Huntington's Disease: a Prospective Intervention Study.

Authors:  Anu Piira; Marleen R van Walsem; Geir Mikalsen; Kjell Haavik Nilsen; Synnove Knutsen; Jan C Frich
Journal:  PLoS Curr       Date:  2013-09-20

6.  Assessment of Sleep Spindle Density among Genetically Positive Spinocerebellar Ataxias Types 1, 2, and 3 Patients.

Authors:  Doniparthi Venkata Seshagiri; Ragasudha Botta; Arun Sasidharan; Pramod Kumar Pal; Sanjeev Jain; Ravi Yadav; Bindu M Kutty
Journal:  Ann Neurosci       Date:  2018-03-08

7.  The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease.

Authors:  Jae Whan Keum; Aram Shin; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Kawther Abu Elneel; Diane Lucente; Tiffany Hadzi; Peter Holmans; Lesley Jones; Michael Orth; Seung Kwak; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Am J Hum Genet       Date:  2016-02-04       Impact factor: 11.025

8.  Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model.

Authors:  Rachel Y Cheong; Barbara Baldo; Muhammad U Sajjad; Deniz Kirik; Åsa Petersén
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

9.  Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study.

Authors:  Marleen R van Walsem; Emilie I Howe; Kristin Iversen; Jan C Frich; Nada Andelic
Journal:  Orphanet J Rare Dis       Date:  2015-09-28       Impact factor: 4.123

10.  Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction.

Authors:  Barbara Baldo; Rana Soylu; Asa Petersén
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.